Entera Bio Ltd

-0.03 (-1.19%)
Earnings Announcements

Entera Bio Reports Q1 Loss Per Share Of $0.13

Published: 05/12/2022 12:34 GMT
Entera Bio Ltd (ENTX) - Entera Bio Reports First Quarter 2022 Financial Results and Business Highlights.
As of March 31, 2022, Entera Had Cash and Cash Equivalents of $20.1 Million, Compared to $24.9 Million As of December 31, 2021.
Expects That Current Cash is Sufficient to Fund Operations Into Q4 of 2022.
Q1 Loss per Share $0.13.
Revenue is expected to be $0.1 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0.13 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.